ESR1 and breast cancer: To assess sensitivity, we separately defined a gold standard list of 11,488 CpGs that are differentially methylated (FDR < 0.05) between TN and ER+ breast cancer cell lines and therefore known to be altered in the epithelial compartment (Additional file 5) [57, 58].